The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...

Cambodia's health ministry today announced another human H5N1 avian flu case of the year, involving a 5-year-old boy from ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.